Promising multiple-epitope recombinant vaccine against foot-and-mouth disease virus type o in swine

Clinical and Vaccine Immunology

Volumn 18, Issue 1, 2011, Pages 143-149

  Shao, Jun Jun ^a   Wong, Chung Kai ^b   Lin, Tong ^a   Lee, Shuk Kwan ^b   Cong, Guo Zheng ^a   Sin, Fion Wai Yee ^b   Du, Jun Zheng ^a   Gao, Shan Dian ^a   Liu, Xiang Tao ^a   Cai, Xue Peng ^a   Xie, Yong ^b   Chang, Hui Yun ^a   Liu, Ji Xing ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS TYPE O; IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; SWINE; VACCINATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHINA; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; IMMUNOGLOBULIN CONSTANT REGIONS; SWINE; SWINE DISEASES; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 78650901066     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00236-10     Document Type: Article

References (44)

1. Alexandersen, S., and A. I. Donaldson. 2002. Further studies to quantify the dose of natural aerosols of foot-and-mouth disease virus for pigs. Epidemiol. Infect. 128:313-323.
2. Barnett, P. V., L. Pullen, L. Williams, and T. R. Doel. 1996. International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants. Vaccine 14:1187-1198.
3. Barteling, S. J., and J. Vreeswijk. 1991. Developments in foot-and-mouth disease vaccines. Vaccine 9:75-88.
4. Beck, E., and K. Strohmaier. 1987. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61:1621-1629. (Pubitemid 17069743)
5. Bittle, J. L., et al. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30-33.
6. Borrego, B., et al. 2006. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24:3889-3899.
7. Brown, F. 1992. New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022-1026.
8. Chan, E. W. C., et al. 2000. An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine. Vaccine 19:538-546.
9. Chung, W. B., et al. 2002. Optimization of foot-and-mouth disease vaccination protocols by surveillance of neutralization antibodies. Vaccine 20:2665-2670.
10. de Avila Botton, S., et al. 2006. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24:3446-3456.
11. DiMarchi, R., et al. 1986. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639-641. (Pubitemid 16061973)
12. Doel, T. R. 2003. FMD vaccines. Virus Res. 91:81-99.
13. Doel, T. R., C. Gale, C. M. Do Amaral, G. Mulcahy, and R. Dimarchi. 1990. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J. Virol. 64:2260-2264. (Pubitemid 20148474)
14. Dunn, C. S., and A. I. Donaldson. 1997. Natural adaption to swine of a Taiwanese isolate of foot-and-mouth disease virus. Vet. Rec. 141:174-175.
15. Eblé, P. L., et al. 2004. Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus. Vaccine 22:1372-1378.
16. Francis, M. J., and L. Black. 1986. Humoral response of pregnant sows to foot and mouth disease vaccination. J. Hyg. (Lond.) 96:501-511.
17. García-Briones, M. M., et al. 2004. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology 322:264-275. (Pubitemid 38521141)
18. Gerner, W., et al. 2006. Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine. Virus Res. 121:223-228. (Pubitemid 44436621)
19. Gerner, W., S. E. Hammer, K. H. Wiesmüller, and A. Saalmüller. 2009. Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J. Virol. 83:4039-4050.
20. Golde, W. T., et al. 2005. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 23:5775-5782.
21. Guzman, E., G. Taylor, B. Charleston, M. A. Skinner, and S. A. Ellis. 2008. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J. Gen. Virol. 89:667-675.
22. He, Y. N., et al. 2008. Construction and immune response characterization of a recombinant pseudorabies virus co-expressing capsid precursor protein (P1) and a multiepitope peptide of foot-and-mouth disease virus in swine. Virus Genes 36:393-400.
23. Kadkhodayan, S., et al. 2000. Cloning, expression, and one-step purification of the minimal essential domain of the light chain of botulinum neurotoxin type A. Protein. Expr. Purif. 19:125-130.
24. Knowles, N. J., A. R. Samuel, P. R. Davies, R. P. Kitching, and A. I. Donaldson. 2001. Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet. Rec. 148:258-259.
25. Lu, Z., et al. 2007. Development and validation of a 3ABC indirect ELISA for differentiation of foot-and-mouth disease virus infected from vaccinated animals. Vet. Microbiol. 125:157-169.
26. Mackay, D. K., et al. 1998. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine 16:446-459. (Pubitemid 28044162)
27. Meloen, R. H., J. I. Casal, K. Dalsgaard, and J. P. Langeveld. 1995. Synthetic peptide vaccines: success at last. Vaccine 13:885-886.
28. Moraes, M. P., et al. 2007. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81:7124-7135.
29. Morgan, D. O., and D. M. Moore. 1990. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am. J. Vet. Res. 51:40-45.
30. Pfaff, E., M. Mussgay, H. O. Bohm, G. E. Schulz, and H. Schaller. 1982. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO. J. 1:869-874.
31. Rodriguez, L. L., et al. 2003. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21:3751-3756.
32. Sanz-Parra, A., et al. 1999. Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J. Gen. Virol. 80:671-679.
33. Sanz-Parra, A., et al. 1999. Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology 259:129-134.
34. Sobrino, F., E. Blanco, M. García-Briones, and V. Ley. 1999. Synthetic peptide vaccines: foot-and-mouth disease virus as a model. Dev. Biol. Stand. 101:39-43.
35. Sørensen, K. J., K. de Stricker, K. C. Dyrting, S. Grazioli, and B. Haas. 2005. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch. Virol. 150:805-814.
36. Su, C. X., et al. 2007. Heterologous expression of FMDV immunodominant epitopes and HSP70 in P. pastoris and the subsequent immune response in mice. Vet. Microbiol. 124:256-263.
37. Sutmoller, P., and R. Casas Olascoaga. 2003. The risks posed by the importation of animals vaccinated against foot and mouth disease and products derived from vaccinated animals: a review. Rev. Sci. Tech. 22:823-835.
38. Taboga, O., et al. 1997. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71:2606-2614. (Pubitemid 27119896)
39. van Lierop, M. J., J. P. Wagenaar, J. M. van Noort, and E. J. Hensen. 1995. Sequences derived from the highly antigenic VP1 region 140 to 160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J. Virol. 69:4511-4514.
40. Winther, M. D., G. Allen, R. H. Bomford, and F. Brown. 1986. Bacterially expressed antigenic peptide from foot-and-mouth disease virus capsid elicits variable immunologic responses in animals. J. Immunol. 136:1835-1840.
41. Wu, Q., M. P. Moraes, and M. J. Grubman. 2003. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine. Virus Res. 93:211-219.
42. Yi, J. Z., et al. 2004. Recombinant bivalent vaccine against foot-and-mouth disease virus serotype O/A infection in guinea pig. Acta Biochim. Biophys. Sin. (Shanghai) 36:589-596.
43. Zaghouani, H., et al. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science 259:224-227. (Pubitemid 23041798)
44. Zamorano, P., et al. 1995. A 10-amino-acid linear sequence of VP1 of foot-and-mouth disease virus containing B- and-T-cell epitopes induces protection in mice. Virology 212:614-621.